GTC Biotherapeutics (fka GTCB)

[mblimon]

I guess that negotiations will start in the biggest markets, i.e. Germany, Great-Britain, France, Spain and Italy. That gives already more than 50% of the EU. Subsequently or parallel Scandinavia, the Benelux, Austria and Poland and finally the smaller newcomers. That would probably leave a very minor share of the European market for 2008.